Jammu, March 9 Jammu and Kashmir Minister for Health and Medical Education Sakeena Itoo emphasized stricter quality checks and greater accountability in the procurement and supply of medicines and equipment across the Union Territory on Monday.
Itoo made the remarks while chairing a high-level review meeting at Civil Secretariat here to assess the performance and functioning of Jammu and Kashmir Medical Supplies Corporation Limited (JKMSCL), an official spokesperson said.
Addressing the officers, the minister said that JKMSCL plays a vital role in the public healthcare delivery system by ensuring the timely availability of medicines, surgical consumables, and medical equipment in government health institutions.
“Any compromise in quality, transparency, or efficiency will not be tolerated, as it directly affects patient safety and the credibility of the public health system,” she said.
While reviewing quality control measures and other protocols, the minister instructed the managing director to maintain constant check on the quality of medicines and equipment procured by the Corporation.
“Tighten quality control protocols at every stage, from procurement and testing to storage and final distribution,” she said.
The minister instructed the corporation to ensure that only certified, safe, and standard-compliant medicines and equipment reach government hospitals, warning that any negligence in quality verification will invite strict action.
“Conduct regular quality audits, enhanced laboratory testing, and strict vendor scrutiny so that suppliers fully adhere to prescribed standards and contractual obligations,” the minister maintained.
While reviewing procurement procedures, supply chain management, inventory status, vendor performance, and existing quality testing mechanisms of the corporation, she directed the MD to take action against firms delaying the supply of essential drugs or medical equipment.
She also sought a detailed report from the Corporation on action taken since 2021 against poorly performing vendors.
Emphasizing on the timely availability of life-saving drugs, the minister urged the Corporation to follow the protocols of prominent medical institutions regarding cancer medicines.
She directed all medical superintendents and hospital administrators to submit the requirements of these drugs as per that protocol.
She also directed the corporation to strengthen grievance redressal mechanisms and ensure immediate response to complaints from healthcare institutions regarding supply delays or quality issues.
Reaffirming the government’s commitment to strengthening healthcare services, the Minister said that accessibility, affordability, and quality of medicines and medical equipment remain at the core priorities of the present Omar Abdullah-led government.
The meeting was informed that during the year 2024-25, 3390 medicine samples were tested, out of which 32 were declared ‘Not of Standard Quality (NoSQ).
In 2025-26, out of 2806 tested samples, 65 were declared NoSQ, with reports of 361 samples still pending, the spokesperson said.